A Study of the Dose Proportionality of Extended Release Paliperidone

NCT00791167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone ER

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.